{
    "clinical_study": {
        "@rank": "6369", 
        "acronym": "Hepar-P", 
        "arm_group": [
            {
                "arm_group_label": "Hepar-P", 
                "arm_group_type": "Experimental", 
                "description": "Hepar-P: Two capsules (250mg x 2), three times daily, orally"
            }, 
            {
                "arm_group_label": "Placebo for Hepar-P", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo: Two capsules, three times daily, orally"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a multi-center, double blind, parallel group placebo controlled randomised trial\n      designed to determine the safety and efficacy of a Standardised Extract of Phyllanthus\n      Niruri (EPN 797) HEPAR-P capsule for the treatment of Non-alcoholic Fatty Liver Disease for\n      a treatment period of 48 weeks"
        }, 
        "brief_title": "Hepar-P Study to Evaluate the Safety and Efficacy of a Standardised Extract of Phyllanthus Niruri for the Treatment of Non-alcoholic Fatty Liver Disease", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Non-alcoholic Fatty Liver Disease", 
        "condition_browse": {
            "mesh_term": [
                "Fatty Liver", 
                "Liver Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or non-pregnant females age 18 years or older\n\n          -  Written informed consent obtained from patient or parents/ guardian\n\n          -  Elevated serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT)\n             levels but less than 2.5times the upper limit of the normal range\n\n          -  Patients with liver biopsy confirmed possible or definite steatohepatitis within the\n             past 12 months prior to enrolment into the trial\n\n          -  Possible steatohepatitis with activity score \u22653 OR definite steatohepatitis with\n             activity score \u22655\n\n          -  A score of at least 1 for hepatocellular ballooning\n\n        Exclusion Criteria:\n\n          -  Pregnant or nursing woman or women of childbearing potential except if\n             post-menopausal, surgically sterile or using accepted method(s) of birth control or\n             having negative pregnancy test\n\n          -  Participation in any trial in which  the patient received an investigational product\n             within 30 days preceding the screening phase of this study\n\n          -  Those persons directly involved in the conduct of the study\n\n          -  Alcohol consumption of more than 20g per day for women or more than 30g per day for\n             men for at least 3 consecutive months during the previous 5 years, as assessed with\n             the use of the Lifetime Drinking History questionnaire and the interview version of\n             the Alcohol Use and Disorders Identification Test (AUDIT)\n\n          -  History of cirrhosis, hepatitis C or other liver diseases\n\n          -  History of heart failure (New York Association Class II to IV)\n\n          -  History of taking medications known to cause steatohepatitis\n\n          -  Any serious medical conditions or disability, which in the opinion of the\n             investigator, would interfere with treatment or assessment or preclude completion of\n             this study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01680003", 
            "org_study_id": "CT11-03"
        }, 
        "intervention": [
            {
                "arm_group_label": "Hepar-P", 
                "intervention_name": "Hepar-P", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo for Hepar-P", 
                "intervention_name": "Placebo for Hepar-P", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 10, 2013", 
        "location": [
            {
                "contact": {
                    "email": "drradzi91@yahoo.co.uk", 
                    "last_name": "Muhammad Radzi Abu Hassan, Dr", 
                    "phone": "+604-7407814"
                }, 
                "facility": {
                    "address": {
                        "city": "Alor Setar", 
                        "country": "Malaysia", 
                        "state": "Kedah", 
                        "zip": "05460"
                    }, 
                    "name": "Sultamah Bahiyah Hospital"
                }, 
                "investigator": {
                    "last_name": "Muhammad Radzi Abu Hassan, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "dr_shashi@hotmail.com", 
                    "last_name": "Shashi Kumar Kumar Bhaskaran, Dr", 
                    "phone": "03-26155555", 
                    "phone_ext": "5691"
                }, 
                "facility": {
                    "address": {
                        "city": "Wilayah Persekutuan", 
                        "country": "Malaysia", 
                        "state": "Kuala Lumpur", 
                        "zip": "50586"
                    }, 
                    "name": "Kuala Lumpur Hospital"
                }, 
                "investigator": {
                    "last_name": "Shashi Kumar Menon Bhaskaran, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "hptee@hotmail.com", 
                    "last_name": "Tee Hoi Poh, Dr", 
                    "phone": "09-5133334"
                }, 
                "facility": {
                    "address": {
                        "city": "Kuantan", 
                        "country": "Malaysia", 
                        "state": "Pahang", 
                        "zip": "25100"
                    }, 
                    "name": "Tengku Ampuan Afzan Hospital"
                }, 
                "investigator": {
                    "last_name": "Tee Hoi Poh, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "drmjayaram@gmail.com", 
                    "last_name": "Jayaram Menon, Dr", 
                    "phone": "+(6)088-517555", 
                    "phone_ext": "7117"
                }, 
                "facility": {
                    "address": {
                        "city": "Kota Kinabalu", 
                        "country": "Malaysia", 
                        "state": "Sabah", 
                        "zip": "88586"
                    }, 
                    "name": "Queen Elizaberth Hospital"
                }, 
                "investigator": {
                    "last_name": "Jayaram Menon, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "drrosaida@moh.gov.my", 
                    "last_name": "Rosaida Mohd Said, Dr", 
                    "phone": "03-42896155"
                }, 
                "facility": {
                    "address": {
                        "city": "Selangor", 
                        "country": "Malaysia", 
                        "zip": "68000"
                    }, 
                    "name": "Ampang Hospital"
                }, 
                "investigator": {
                    "last_name": "Rosaida Mohd Said, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Malaysia"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy and Safety of HEPAR-P Capsule for the Treatment of Non-alcoholic Fatty Liver Disease (NAFLD)", 
        "other_outcome": {
            "measure": "Adverse events reporting, physical examinations and laboratory tests", 
            "safety_issue": "Yes", 
            "time_frame": "48 weeks"
        }, 
        "overall_official": [
            {
                "affiliation": "Sultanah Bahiyah Hospital, Alor Star", 
                "last_name": "Muhammad Radzi Abu Hassan, Dr", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Selayang Hospital, Selangor", 
                "last_name": "Tan Soek Siam, Dr", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Tengku Ampuau Afzan Hospital, Kuantan", 
                "last_name": "Tee Hoi Poh, Dr", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ampang Hospital, Selangor", 
                "last_name": "Rosaida Mohd Said, Dr", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Kuala Lumpur Hospital", 
                "last_name": "Shashi Kumar Bhaskaran, Dr", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Queen Elizaberth Hospital, Sabah", 
                "last_name": "Jayaram Menon, Dr", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Malaysia: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Improvement in serum aspartate aminotransferase and alanine aminotransferase levels", 
            "safety_issue": "No", 
            "time_frame": "48 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01680003"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Histologic findings including degree of steatosis, lobular inflammation, hepatocellular ballooning and fibrosis and overall disease activity score", 
            "safety_issue": "No", 
            "time_frame": "48 weeks"
        }, 
        "source": "Nova Laboratories Sdn Bhd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nova Laboratories Sdn Bhd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}